tykhr
sign in
free sign up
Taysha Gene Therapies Inc
Biotechnology
Healthcare
TSHA
268 M shares
NASDAQ US
traded
25 Jun 2025
listed
no
open
2.37
52 week high
3.24
high
2.46
52 week low
1.27
low
2.31
growth
8.44 %
previous Close
2.37
P/E ratio
market cap
359 M
div yield
0
usd
Sep 2024
qoq
revenue
1.79 M
60.79 %
net incoming
-25.52 M
-21.96 %
eps
0.00 %
20.89 %
eps surprise
20.89 %
net profit margin
-1427.52 %
454.00 %
operating incoming
-25.90 M
-21.59 %
net change in cash
-12.90 M
-126.46 %
cash on hand
158 M
-8.72 %
cost of revenue
0.00 %
top